AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RIBAVIRINE

11 registrations across 3 African markets— 5 active

Markets with RIBAVIRINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NEABETOL
Solution buvable / 40mg/ml
🇹🇳TunisiaNEAPOLIS PHARMAexpiredJul 2021
RIBAVIL 500MG COMPRIME PELLICULE BOITE DE 10🇨🇮Côte d'IvoireGENIX PHARMA PVT LTDexpiredJan 2020
RIBERYN
Comprimé pelliculé / 400 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
RIBERYN
Comprimé pelliculé / 200 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
RIBERYN
Comprimé pelliculé / 200 mg
🇹🇳TunisiaTAHA PHARMAexpiredApr 2016
RIBERYN
Comprimé pelliculé / 600 mg
🇹🇳TunisiaTAHA PHARMAexpiredApr 2016
COPEGUS
COMPRIME PELLICULE
🇲🇦Moroccoactive
REBETOL
GELULE
🇲🇦Moroccoactive
REBETOL
GELULE
🇲🇦Moroccoactive
REBETOL
GELULE
🇲🇦Moroccoactive
COPEGUS
COMPRIME PELLICULE
🇲🇦Moroccoactive

RIBAVIRINE in Africa — Regulatory Overview

RIBAVIRINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 5 (45%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.